Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1991 Oct;50(10):685–690. doi: 10.1136/ard.50.10.685

Neutrophil function in patients with primary Sjögren's syndrome: relation to infection propensity.

B Gudbjörnsson 1, N Feltelius 1, R Hällgren 1, P Venge 1
PMCID: PMC1004531  PMID: 1958091

Abstract

The function of neutrophils was studied in 23 consecutive patients with primary Sjögren's syndrome and in 35 healthy controls. Nineteen patients (83%) had extraglandular symptoms and nine patients (39%) had recurrent bacterial infections. The patients had a marked reduction of neutrophil adherence, especially those with recurrent bacterial infections, and reduced opsonic activity of plasma. Increased random migration of isolated neutrophils was found in the patients with a propensity for bacterial infections. Chemotaxis and chemokinesis, phagocytosis, chemiluminescence production, and the intracellular neutrophil contents of lactoferrin and lysozyme were normal. The various aspects of neutrophil function tested in this study were not related to disease duration or to inflammatory disease activity. The impaired neutrophil adherence may play a part in the increased propensity for bacterial infections seen in patients with primary Sjögren's syndrome.

Full text

PDF
685

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLOCH K. J., BUCHANAN W. W., WOHL M. J., BUNIM J. J. SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES. Medicine (Baltimore) 1965 May;44:187–231. [PubMed] [Google Scholar]
  2. Bass D. A., Olbrantz P., Szejda P., Seeds M. C., McCall C. E. Subpopulations of neutrophils with increased oxidative product formation in blood of patients with infection. J Immunol. 1986 Feb 1;136(3):860–866. [PubMed] [Google Scholar]
  3. Bondestam M., Håkansson L., Foucard T., Venge P. Defects in polymorphonuclear neutrophil function and susceptibility to infection in children. Scand J Clin Lab Invest. 1986 Nov;46(7):685–694. doi: 10.3109/00365518609083732. [DOI] [PubMed] [Google Scholar]
  4. Cheson B. D., Christensen R. L., Sperling R., Kohler B. E., Babior B. M. The origin of the chemiluminescence of phagocytosing granulocytes. J Clin Invest. 1976 Oct;58(4):789–796. doi: 10.1172/JCI108530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Henson P. M. Membrane receptors on neutrophils. Immunol Commun. 1976;5(9):757–774. doi: 10.3109/08820137609047618. [DOI] [PubMed] [Google Scholar]
  6. Horwitz M. A. Phagocytosis of microorganisms. Rev Infect Dis. 1982 Jan-Feb;4(1):104–123. doi: 10.1093/clinids/4.1.104. [DOI] [PubMed] [Google Scholar]
  7. Hunninghake G. W., Fauci A. S. Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis. 1979 Mar;119(3):471–503. doi: 10.1164/arrd.1979.119.3.471. [DOI] [PubMed] [Google Scholar]
  8. Hällgren R., Håkansson L., Venge P. Kinetic studies of phagocytosis. I. The serum independent particle uptake by PMN from patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 1978 Jan-Feb;21(1):107–113. doi: 10.1002/art.1780210117. [DOI] [PubMed] [Google Scholar]
  9. Hällgren R., Jansson L., Venge P. Kinetic studies of phagocytosis of IgG-coated latex particles with a thrombocyte counter. J Lab Clin Med. 1977 Nov;90(5):786–795. [PubMed] [Google Scholar]
  10. Håkansson L., Hällgren R., Venge P. Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J Clin Invest. 1980 Aug;66(2):298–305. doi: 10.1172/JCI109857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Håkansson L., Venge P. The chemotactic activity of normal and complement-activated serum as measured by the leading-front method using a Boyden chamber. Scand J Immunol. 1984 Jan;19(1):63–73. doi: 10.1111/j.1365-3083.1984.tb00900.x. [DOI] [PubMed] [Google Scholar]
  12. Håkansson L., Venge P. The influence of serum on random migration and chemotaxis of polymorphonuclear leucocytes: methodological evaluation using sera from infection-prone patients and normals. Scand J Immunol. 1980;11(3):271–282. doi: 10.1111/j.1365-3083.1980.tb00235.x. [DOI] [PubMed] [Google Scholar]
  13. Manthorpe R., Oxholm P., Prause J. U., Schiødt M. The Copenhagen criteria for Sjögren's syndrome. Scand J Rheumatol Suppl. 1986;61:19–21. [PubMed] [Google Scholar]
  14. Moutsopoulos H. M., Chused T. M., Mann D. L., Klippel J. H., Fauci A. S., Frank M. M., Lawley T. J., Hamburger M. I. Sjögren's syndrome (Sicca syndrome): current issues. Ann Intern Med. 1980 Feb;92(2 Pt 1):212–226. doi: 10.7326/0003-4819-92-2-212. [DOI] [PubMed] [Google Scholar]
  15. Olofsson T., Olsson I., Venge P. Myeloperoxidase and lactoferrin of blood neutrophils and plasma in chronic granulocytic leukaemia. Scand J Haematol. 1977 Feb;18(2):113–120. doi: 10.1111/j.1600-0609.1977.tb02080.x. [DOI] [PubMed] [Google Scholar]
  16. Pauksens K., Sjölin J., Venge P. Chemiluminescence of polymorphonuclear leukocytes and whole blood during acute bacterial infection. Scand J Infect Dis. 1989;21(3):277–284. doi: 10.3109/00365548909035697. [DOI] [PubMed] [Google Scholar]
  17. Pennec Y. L., Gentric A. H., Jouquan J. R., Youinou P. Polymorphonuclear cell functions in patients with primary Sjögren's syndrome. Clin Exp Rheumatol. 1988 Jul-Sep;6(3):293–296. [PubMed] [Google Scholar]
  18. Schmekel B., Håkansson L., Hällgren R., Stålenheim G., Venge P. Serum-mediated stimulation and inhibition of neutrophil locomotion in sarcoidosis. Eur J Respir Dis. 1984 Nov;65(8):592–599. [PubMed] [Google Scholar]
  19. Siegbahn A., Venge P., Nilsson K., Simonson B. Identification of a chemokinetic inhibitor in serum from patients with chronic lymphocytic leukaemia. Scand J Haematol. 1982 Feb;28(2):122–131. doi: 10.1111/j.1600-0609.1982.tb00504.x. [DOI] [PubMed] [Google Scholar]
  20. Staples P. J., Gerding D. N., Decker J. L., Gordon R. S., Jr Incidence of infection in systemic lupus erythematosus. Arthritis Rheum. 1974 Jan-Feb;17(1):1–10. doi: 10.1002/art.1780170102. [DOI] [PubMed] [Google Scholar]
  21. Strimlan C. V., Rosenow E. C., 3rd, Divertie M. B., Harrison E. G., Jr Pulmonary manifestations of Sjögren's syndrome. Chest. 1976 Sep;70(03):354–361. doi: 10.1378/chest.70.3.354. [DOI] [PubMed] [Google Scholar]
  22. Weiss J., Elsbach P., Olsson I., Odeberg H. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem. 1978 Apr 25;253(8):2664–2672. [PubMed] [Google Scholar]
  23. Wolach B., Baehner R. L., Boxer L. A. Review: clinical and laboratory approach to the management of neutrophil dysfunction. Isr J Med Sci. 1982 Sep;18(9):897–916. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES